- Opinion to be reviewed by European Commission - WARREN, N.J., Oct. 18, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has maintained its negative opinion on the...
CHMP Maintains Negative Opinion on Translarna™ Reexamination
Seaking AlphaSeeking Alpha / Seaking Alpha 5 hours ago 1 Views
Comments